Jazz Pharmaceuticals plc
JAZZ
$125.24
$0.020.02%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.67B | 2.57B | 2.99B | 2.62B | 1.98B |
| Total Receivables | 714.00M | 652.99M | 716.77M | 723.64M | 698.04M |
| Inventory | 504.99M | 492.78M | 480.45M | 539.30M | 542.56M |
| Prepaid Expenses | 164.00M | 150.28M | 177.41M | 155.13M | 134.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 297.55M | 259.79M | 260.58M | 354.20M | 325.85M |
| Total Current Assets | 3.35B | 4.13B | 4.63B | 4.39B | 3.68B |
|
|
|||||
| Total Current Assets | 3.35B | 4.13B | 4.63B | 4.39B | 3.68B |
| Net Property, Plant & Equipment | 248.06M | 228.05M | 227.00M | 253.59M | 242.43M |
| Long-term Investments | 1.84B | 1.76B | 1.72B | 1.80B | 1.74B |
| Goodwill | 1.84B | 1.76B | 1.72B | 1.80B | 1.74B |
| Total Other Intangibles | 4.77B | 4.72B | 4.76B | 5.14B | 5.08B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 728.39M | 696.31M | 679.88M | 658.54M | 617.31M |
| Total Assets | 10.94B | 11.53B | 12.01B | 12.26B | 11.36B |
|
|
|||||
| Total Accounts Payable | 89.37M | 95.93M | 77.87M | 85.43M | 97.10M |
| Total Accrued Expenses | 820.56M | 840.97M | 821.98M | 805.32M | 749.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.04B | 44.44M | 45.78M | 50.10M | 622.95M |
| Total Finance Division Other Current Liabilities | 118.92M | 241.27M | 92.94M | 89.13M | 86.91M |
| Total Other Current Liabilities | 118.92M | 241.27M | 92.94M | 89.13M | 86.91M |
| Total Current Liabilities | 2.07B | 1.22B | 1.04B | 1.03B | 1.56B |
|
|
|||||
| Total Current Liabilities | 2.07B | 1.22B | 1.04B | 1.03B | 1.56B |
| Long-Term Debt | 4.34B | 5.34B | 6.08B | 6.08B | 5.10B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 55.11M | 38.78M | 43.50M | 71.12M | 67.62M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 775.85M | 761.76M | 758.79M | 900.35M | 874.64M |
| Total Liabilities | 7.24B | 7.36B | 7.92B | 8.08B | 7.60B |
|
|
|||||
| Common Stock & APIC | 4.00B | 3.93B | 3.91B | 3.84B | 3.78B |
| Retained Earnings | 191.31M | 1.03B | 1.13B | 936.23M | 871.18M |
| Treasury Stock & Other | -485.24M | -785.08M | -947.14M | -602.87M | -887.70M |
| Total Common Equity | 3.71B | 4.17B | 4.09B | 4.17B | 3.76B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.71B | 4.17B | 4.09B | 4.17B | 3.76B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.71B | 4.17B | 4.09B | 4.17B | 3.76B |
|
|
|||||